Press Releases

LIQUID STABLE, MULTI-ANALYTE ISE STANDARD KIT AVAILABLE FROM VERICHEM LABORATORIES

MR Solutions participates in the first nanomedicine joint annual meeting in Dijon

MR Solutions' 7T PET/MRI preclinical imaging system for nanoparticle imaging shown at the first nanomedicine joint annual meeting in Dijon in December 2019.

Accumen Launches Healthcare Performance Publication

New publication combines expert opinions with current news, upcoming events and trending facts

Prescient Medicine and Erasmus MC Partner to Study Opioid Addiction Risk

Proscia® and Johns Hopkins School of Medicine Collaborate to Bring Artificial Intelligence Applications to Several High-Impact Diseases and Specialties in Pathology

Proscia, a leading provider of AI-enabled digital pathology software, and Johns Hopkins School of Medicine, one of the leading academic medical centers in the U.S., will collaborate on the development of computational applications that incorporate artificial intelligence (AI) to advance the practice of pathology for multiple diseases.

QuantuMDx and Ontera collaborate to advance sepsis diagnosis

QuantuMDx Group Limited and Ontera, Inc have announced a collaboration to create a next-generation solution for blood stream infection and drug resistance detection.

LIQUID STABLE HDL CHOLESTEROL CALIBRATION VERIFICATIONKIT AVAILABLE FROM VERICHEM LABORATORIES

BioIVT Announces the Launch of its Next-generation Sequencing Service

Comprehensive service includes project design, specimen selection, library preparation, sequencing and bioinformatics support

MR Solutions installs the first 7T PET/MR integrated imaging system in Israel

MR Solutions has installed the first 7T PET/MR preclinical imaging system in Israel. The dry magnet system is helping to advance medical research at the Wohl Institute for Translational Medicine, part of the Hadassah Hebrew University Medical Center in Jerusalem.

LEO Pharma Joins Certara’s PBPK Simcyp Simulator Consortium

37 leading biopharmaceutical companies now participate in this unique research and development group focused on advancing model-informed drug development

WCG Launches AIMS 4.1 Platform with Enhanced Endpoint Adjudication Capabilities to Facilitate Expert Review of Clinical Trial Data

Latest iteration of AIMS (Adjudication Information Management System) has an enhanced user interface to improve efficiency

Proscia® and the American Cancer Society Partner to Give Patients Hope for Effective Treatment

Proscia, a leading provider of AI-enabled digital pathology software, and the American Cancer Society (ACS) announce a partnership to advance their shared goal of improving patient outcomes through successful treatment. Proscia has formally pledged a portion of its 2020 revenue to the ACS Hope Lodge program, which provides free lodging for patients and their caregivers when the best hope for effective treatment is far from home.* The ACS will help Proscia to raise awareness of the impact of digital pathology among its national network of payers, providers, and advocates.

Thermo Fisher Scientific to Bring One-Day Genomic Profiling to Hematology Oncology

Thermo Fisher announces comprehensive myeloid assay available in 2020 to run on the Ion Torrent Genexus System at the 61st American Society of Hematology (ASH) Annual Meeting & Exposition

BioIVT to Host Drug Discovery Webinar on Gene Silencing Using siRNA In Hepatocyte Co-cultures

Webinar that will discuss how small interfering RNA (siRNA) molecules can be used to selectively suppress hepatic genes in an in vitro liver model.

Epigenomics AG Reports on New Micro-Simulation Study Results Published in Cancer Medicine Indicating That Epi proColon® Provides Clinically Meaningful Reductions in Incidence and Mortality of Colorectal Cancer

CSA Medical, Inc. Announces European Approval for its RejuvenAir® System for COPD Patients with Chronic Bronchitis

NiceLabel Solution Chosen by Boehringer Ingelheim to support standardized labeling worldwide

NiceLabel's solution will support a worldwide standardized labeling process for Boehringer Ingelheim, a global pharmaceutical company.

Certara Announces the Availability of PK Submit, its Pharmacokinetic CDISC Technology Solution

PK Submit generates PK CDISC domains automatically, allowing sponsors to file regulatory submissions faster, while also improving data organization and compliance 

City of San Diego Proclaims mRNA Day in Celebration of New Maravai LifeSciences Headquarters

mRNA Day is being celebrated in the City of San Diego following a proclamation in honor of Maravai LifeSciences and the grand opening of its new headquarters in the City. A leader in providing reagents to researchers, biotherapeutics manufacturers and OEM partners worldwide; Maravai invested $40 million into the 105,000 square-foot headquarters located in Sorrento Valley, which features a 50,000 square foot manufacturing facility with five state-of-the-art cleanrooms for TriLink BioTechnologies, a leader in the synthesis of highly modified nucleic acids including oligonucleotides and messenger RNA (mRNA) for research, diagnostics, and therapeutic applications. Maravai’s investment creates five new manufacturing suites for TriLink that meet the FDA’s Current Good Manufacturing Practices (cGMP) requirements, which can help TriLink increase production of complex materials like mRNA. mRNA is on track to become one of the fastest growing segments of the drug industry and has the potential to treat almost any disease. With its increased cGMP capacity, TriLink can help its global customers bring their biomedical breakthroughs based on mRNA and other modified nucleic acids through clinical trials faster and accelerate improvements in human health care.

XACT Robotics Appoints Industry Veteran Brian L. Allen as its Vice President of Sales and Marketing